Ovation Science Inc.
OVAT
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -44.78% | -38.35% | 42.67% | 81.22% | 34.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -44.78% | -38.35% | 42.67% | 81.22% | 34.86% |
| Cost of Revenue | -71.19% | -83.86% | -81.25% | 47.45% | 1,304.76% |
| Gross Profit | -30.06% | -10.52% | 253.85% | 95.64% | -10.34% |
| SG&A Expenses | -28.37% | -33.42% | -35.03% | -31.98% | -12.44% |
| Depreciation & Amortization | -100.00% | -83.33% | -58.33% | -33.33% | -8.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.76% | -34.88% | -37.61% | -29.44% | -17.16% |
| Operating Income | 25.73% | 34.35% | 44.16% | 38.36% | 22.88% |
| Income Before Tax | 36.96% | 31.86% | 53.67% | 45.64% | 19.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.96% | 31.86% | 53.67% | 45.64% | 19.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.96% | 31.86% | 53.67% | 45.64% | 19.91% |
| EBIT | 25.73% | 34.35% | 44.16% | 38.36% | 22.88% |
| EBITDA | 25.72% | 34.35% | 44.25% | 38.45% | 22.94% |
| EPS Basic | 39.72% | 38.56% | 57.50% | 51.47% | 29.50% |
| Normalized Basic EPS | 42.22% | 40.82% | 58.59% | 52.31% | 28.57% |
| EPS Diluted | 39.72% | 38.56% | 57.50% | 51.47% | 29.50% |
| Normalized Diluted EPS | 42.22% | 40.82% | 58.59% | 52.31% | 28.57% |
| Average Basic Shares Outstanding | 6.43% | 11.38% | 6.94% | 10.53% | 12.32% |
| Average Diluted Shares Outstanding | 6.43% | 11.38% | 6.94% | 10.53% | 12.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |